Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Home  /  Forum  /  Relief therapeutics  /  Relief therapeutics Holding

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel RELIEF THERAPEUTICS N ZSE:RLF.CH, CH1251125998

  • 1,215 17 apr 2024 16:15
  • -0,045 (-3,57%) Dagrange 1,215 - 1,230
  • 2.996 Gem. (3M) 15K

Relief therapeutics Holding

9.103 Posts
Pagina: «« 1 ... 75 76 77 78 79 ... 456 »» | Laatste | Omlaag ↓
  4. forum rang 5 MisterBlues 19 augustus 2020 23:17
    van YF, John:

    I think the following catalysts will happen in the coming 4 weeks. This is my opinion only and the timing may be not exactly as I anticipated. Regardless, they are coming.

    Week 1 (this week): data of 21 new patients already out. 19/21 recovered in days. Wait for news release!

    Week 2: partnership for manufacturing and distribution

    Week 3: interim analysis results of 102 patients. Positive readout, data will be discussed with FDA.

    Week 4: FDA approval (may be EUA for a fast approval); Trump mention it with government funding, etc.

    The SP will skyrocket. Folks, forget about share numbers and whatever. It is the most challenging time in decades. What should be the price for a drug that saves the lives in days and can reopen the world?
  5. forum rang 5 MisterBlues 19 augustus 2020 23:19
    Van YF, een zekere uh:

    Methodist Hospital just made an immediate press release stating its available to any doctor/hospital and not just as last resort! HUGE!!
    “The drug is called RLF-100 and is also known as aviptadil. It has been approved by the FDA for emergency use at multiple clinical sites in patients who are too ill to enter the FDA’s Phase 2/3 trials.

    According to a press release from the drug maker NeuroRX, independent researchers have reported that aviptadil blocked replication of the SARS coronavirus in human lung cells and monocytes.

    The drug has been successful in reducing lung inflammation and so the FDA now says any doctor at any hospital can request this treatment to help severely ill COVID-19 patients.”
  6. forum rang 5 MisterBlues 19 augustus 2020 23:28
    Van YF, een zekere Michael over de geschiedenis van Aviptadil en de vele mogelijke toepassingen:

    FDA approval is coming for these reasons: 1. It works, according to latest clinical studies (thanks @chartgirl72 for the early news). 2. Safety profile is well documented for over 30 years so there's no reason not to approve it since the efficacy in early scientific studies is more than impressive. 3. NueroRx went out of their way to trademark it SAMIVIR and SAMIVIP in honor of their late colleague and the scientist who co-discovered VIP, Sami Said MD (RIP 2013). Dr. Said's dream was to see VIP save lives as a commercial therapy. I don't think his peers would name it after him unless this dream was going to be realized in a big way (a bit of a stretch I know, but it's quite the post-humous honor right?). Furthermore, I've read vasoactive intestinal peptide studies all the way back to 1989. VIP is stable as a synthetic peptide in the form of Aviptadil (SAMIVIR is a cooler name too). After FDA approval this may even help with asthma in inhaled form. That's big time. (In the past peptidases broke down natural VIP too fast for much therapy to be realized but now that it is in stable form as a synthetic peptide, it opens up multiple revenue streams for tx including pulmonary fibrosis, sarcoidosis, asthma (maybe), ED (for sure), Weight loss, and how do I put this politely... vaginal lubrication. (Sorry, that's the medical term).

    Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with Asthma:

    www.nejm.org/doi/10.1056/NEJM19890511...
  11. forum rang 10 DeZwarteRidder 20 augustus 2020 07:30
    quote:

    MisterBlues schreef op 19 augustus 2020 23:28:

    Van YF, een zekere Michael over de geschiedenis van Aviptadil en de vele mogelijke toepassingen:

    FDA approval is coming for these reasons: 1. It works, according to latest clinical studies (thanks @chartgirl72 for the early news). 2. Safety profile is well documented for over 30 years so there's no reason not to approve it since the efficacy in early scientific studies is more than impressive. 3. NueroRx went out of their way to trademark it SAMIVIR and SAMIVIP in honor of their late colleague and the scientist who co-discovered VIP, Sami Said MD (RIP 2013). Dr. Said's dream was to see VIP save lives as a commercial therapy. I don't think his peers would name it after him unless this dream was going to be realized in a big way (a bit of a stretch I know, but it's quite the post-humous honor right?). Furthermore, I've read vasoactive intestinal peptide studies all the way back to 1989. VIP is stable as a synthetic peptide in the form of Aviptadil (SAMIVIR is a cooler name too). After FDA approval this may even help with asthma in inhaled form. That's big time. (In the past peptidases broke down natural VIP too fast for much therapy to be realized but now that it is in stable form as a synthetic peptide, it opens up multiple revenue streams for tx including pulmonary fibrosis, sarcoidosis, asthma (maybe), ED (for sure), Weight loss, and how do I put this politely... vaginal lubrication. (Sorry, that's the medical term).

    Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with Asthma:

    www.nejm.org/doi/10.1056/NEJM19890511...
    Jammer dat het patent is afgelopen en dat iedereen het kan namaken.............
  13. Hangyodon 20 augustus 2020 07:40
    quote:

    DeZwarteRidder schreef op 20 augustus 2020 07:30:

    [...]
    Jammer dat het patent is afgelopen en dat iedereen het kan namaken.............
    Waarom zoekt u altijd iets om te bashen. Je zei dat dit fake is en dat medicijn niet werkt etc etc.. nu blijkt dat dit goed werkt tegen covid ga je weer iets anders zoeken om verder te bashen.
  14. Question 20 augustus 2020 07:48
    quote:

    Hangyodon schreef op 20 augustus 2020 07:40:

    [...]

    Waarom zoekt u altijd iets om te bashen. Je zei dat dit fake is en dat medicijn niet werkt etc etc.. nu blijkt dat dit goed werkt tegen covid ga je weer iets anders zoeken om verder te bashen.
    Je kiest zelf waar je in belegt en je kiest zelf wie je serieus neemt! Je kunt ook dingen negeren. Zwarte ridder heeft geen andere bezigheden. Hij/zij heeft 59000+ Iets geschreven of gespuwd. Dan kun je ondertussen ook zaken verrichten die wellicht positief bijdragen aan de maatschappij.... Echt negeren die handel
9.103 Posts
Pagina: «« 1 ... 75 76 77 78 79 ... 456 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium drie voorbeelden van IEX Premium: de exclusieve content op de site, de app op een smartphone en IEX Magazine.

Benieuwd naar onze analyses en kooptips?

Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!

Word abonnee

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!